Book Value per Share: TherapeuticsMD Corp (TXMD)

TherapeuticsMD, Inc. (TXMD) is completing a financial restructuring, focusing on collecting licensing fees to settle its debts. The change in BVPS on the GURU.Markets chart visualizes this process, where the value of 2.35 expresses the metric level. Business resilience is supported by hormone patents and contracts with insurance networks, although geopolitical conflicts and sanctions complicate logistics and the expansion of drugs into foreign markets.

TherapeuticsMD Corp (TXMD): Share Book Value from 07/04/2022 to 10/28/2026

TherapeuticsMD Inc - analytical breakdowns and key metrics (TXMD)

- price and consensus price forecast:

Price Chart TherapeuticsMD Corp|TXMD - Consensus Target

- market capitalization data:

Market Capitalization TherapeuticsMD, Inc.|TXMD - Business Value

- book capitalization data:

Net Assets per Single Share TherapeuticsMD|TXMD - Net Asset Value|Market Capitalization to Book Value Ratio therapeuticsmd.com|TXMD - Aggregate Asset Value

- debt and liquidity data:

Total Debt to Capital TherapeuticsMD, Inc.|TXMD - Long-Term Debt to Capital|Short-Term Debt to Equity TherapeuticsMD Corp|TXMD - Aggregate Debt Obligations|Debt to Book Capitalization Ratio TherapeuticsMD, Inc.

Fundamental company valuation:therapeuticsmd.com - TXMD

Manufactured products of TherapeuticsMD Corp

Book value per share determines the intrinsic value of a business by subtracting liabilities from total equity to reveal the investor's actual fundamental cushion. By analyzing the trend of book value per share, one can assess how TherapeuticsMD, Inc. (TXMD) expenditures on environmental plant modernization and waste disposal impact the company's net assets within its sustainable development strategy.

Competitors of TherapeuticsMD, Inc. (TXMD)

OGN: Net Assets per Single Share|DARE - Accounting Value per Share|Book Value per Share Palatin Technologies